Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0002049575-25-000002
Filing Date
2025-06-16
Accepted
2025-06-16 19:57:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 17708
2 JOINT FILING AGREEMENT jointfilingagmt.pdf EX-1 10956
  Complete submission text file 0002049575-25-000002.txt   34829
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Subject) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92230 | Film No.: 251051555
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address TWO TOWNE SQUARE SUITE 810 SOUTHFIELD MI 48076
Business Address TWO TOWNE SQUARE SUITE 810 SOUTHFIELD MI 48076 248-723-6650
V-CO Investors LLC (Filed by) CIK: 0002049575 (see all company filings)

EIN.: 992878853 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SCHEDULE 13D